Literature DB >> 18926762

Structures and biological functions of IL-31 and IL-31 receptors.

Qing Zhang1, Prabhakar Putheti, Qiang Zhou, Quansheng Liu, Wenda Gao.   

Abstract

Interleukin-31, produced mainly by activated CD4(+) T cells, is a newly discovered member of the gp130/IL-6 cytokine family. Unlike all the other family members, IL-31 does not engage gp130. Its receptor heterodimer consists of a unique gp130-like receptor chain IL-31RA, and the receptor subunit OSMRbeta that is shared with another family member oncostatin M (OSM). Binding of IL-31 to its receptor activates Jak/STAT, PI3K/AKT and MAPK pathways. IL-31 acts on a broad range of immune- and non-immune cells and therefore possesses potential pleiotropic physiological functions, including regulating hematopoiesis and immune response, causing inflammatory bowel disease, airway hypersensitivity and dermatitis. This review summarizes the recent findings on the biological characterization and physiological roles of IL-31 and its receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18926762      PMCID: PMC2659402          DOI: 10.1016/j.cytogfr.2008.08.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  64 in total

1.  New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis.

Authors:  A Trautmann; M Akdis; E B Bröcker; K Blaser; C A Akdis
Journal:  Trends Immunol       Date:  2001-10       Impact factor: 16.687

2.  Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.

Authors:  M Ichihara; T Hara; H Kim; T Murate; A Miyajima
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  Cloning and characterization of a specific receptor for mouse oncostatin M.

Authors:  R A Lindberg; T S Juan; A A Welcher; Y Sun; R Cupples; B Guthrie; F A Fletcher
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

5.  Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells.

Authors:  Stephan Brand; Takanori Sakaguchi; Xiubin Gu; Sean P Colgan; Hans-Christian Reinecker
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

6.  Specific inhibition of Stat3 signal transduction by PIAS3.

Authors:  C D Chung; J Liao; B Liu; X Rao; P Jay; P Berta; K Shuai
Journal:  Science       Date:  1997-12-05       Impact factor: 47.728

7.  The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.

Authors:  Dorthe Aasland; Birgit Oppmann; Joachim Grötzinger; Stefan Rose-John; Karl-Josef Kallen
Journal:  J Mol Biol       Date:  2002-01-25       Impact factor: 5.469

8.  The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.

Authors:  A Hammacher; R T Richardson; J E Layton; D K Smith; L J Angus; D J Hilton; N A Nicola; J Wijdenes; R J Simpson
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

9.  Inhibition of Stat1-mediated gene activation by PIAS1.

Authors:  B Liu; J Liao; X Rao; S A Kushner; C D Chung; D D Chang; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Drosophila unpaired encodes a secreted protein that activates the JAK signaling pathway.

Authors:  D A Harrison; P E McCoon; R Binari; M Gilman; N Perrimon
Journal:  Genes Dev       Date:  1998-10-15       Impact factor: 11.361

View more
  80 in total

Review 1.  [Cutaneous amyloidosis].

Authors:  S Schreml; R-M Szeimies; M Landthaler; P Babilas
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

2.  Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.

Authors:  Ramakrishna Edukulla; Brijendra Singh; Anil G Jegga; Vishwaraj Sontake; Stacey R Dillon; Satish K Madala
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

3.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Authors:  Mehdi Najar; Hussein Fayyad-Kazan; Wissam H Faour; Makram Merimi; Etienne M Sokal; Catherine A Lombard; Hassan Fahmi
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

Review 4.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

5.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.

Authors:  E Ayimba; J Hegewald; A Y Ségbéna; R G Gantin; C J Lechner; A Agosssou; M Banla; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

Review 6.  Basic mechanisms of itch.

Authors:  C Potenzieri; B J Undem
Journal:  Clin Exp Allergy       Date:  2011-06-06       Impact factor: 5.018

7.  Pathogenesis and treatment of pruritus.

Authors:  Malcolm W Greaves
Journal:  Curr Allergy Asthma Rep       Date:  2010-07       Impact factor: 4.806

8.  Itch in dermatomyositis: the role of increased skin interleukin-31.

Authors:  H J Kim; M Zeidi; D Bonciani; S M Pena; J Tiao; S Sahu; V P Werth
Journal:  Br J Dermatol       Date:  2018-06-21       Impact factor: 9.302

9.  Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors:  Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

10.  Correlation of IL-31 gene polymorphisms with susceptibility and clinical recurrence of bladder cancer.

Authors:  Qin Li; Tielong Tang; Peng Zhang; Chenlu Liu; Yan Pu; Yan Zhang; Huizi Song; Yanyun Wang; Yaping Song; Min Su; Bin Zhou; Lin Zhang
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.